Home
Knowledge Base
References
Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells.

Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells.

Daniels TR, Ng PP, Delgado T, Lynch MR, Schiller G, Helguera G, Penichet ML (2007) Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells. Mol Cancer Ther 6:2995-3008. doi: 10.1158/1535-7163.MCT-07-0330

Summary: The human transferrin receptor (hTfR) is overexpressed in malignant cells. Using Advanced Targeting System’s custom biotinylation service, the authors combined an anti-hTfR antibody-avidin fusion protein with biotinylated saporin (Cat. #PR-01, saporin alone), and examined the effect of the combined complex on cancer cells in vitro. Although the antibody-avidin fusion protein has an intrinsic cytotoxic effect, the fusion protein-saporin complex was able to eliminate the population of cells that showed resistance to the fusion protein alone.